These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 9799755)
41. Reference intervals of bone turnover markers in healthy premenopausal women: results from a cross-sectional European study. Eastell R; Garnero P; Audebert C; Cahall DL Bone; 2012 May; 50(5):1141-7. PubMed ID: 22348982 [TBL] [Abstract][Full Text] [Related]
42. Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in community dwelling postmenopausal Hungarian women. Bhattoa HP; Bettembuk P; Ganacharya S; Balogh A Osteoporos Int; 2004 Jun; 15(6):447-51. PubMed ID: 15205715 [TBL] [Abstract][Full Text] [Related]
43. Effects of intranasal 17beta-estradiol on bone turnover and serum insulin-like growth factor I in postmenopausal women. Garnero P; Tsouderos Y; Marton I; Pelissier C; Varin C; Delmas PD J Clin Endocrinol Metab; 1999 Jul; 84(7):2390-7. PubMed ID: 10404809 [TBL] [Abstract][Full Text] [Related]
44. Correlations of new markers of bone formation and resorption in kidney transplant recipients. Małyszko J; Wołczyński S; Małyszko JS; Konstantynowicz J; Kaczmarski M; Myśliwiec M Transplant Proc; 2003 Jun; 35(4):1351-4. PubMed ID: 12826157 [TBL] [Abstract][Full Text] [Related]
45. [Bone resorption markers]. Takahashi M; Inoue T Rinsho Byori; 1996 May; 44(5):415-22. PubMed ID: 8676559 [TBL] [Abstract][Full Text] [Related]
46. Investigation of bone disease using isomerized and racemized fragments of type I collagen. Cloos PA; Fledelius C; Christgau S; Christiansen C; Engsig M; Delmas P; Body JJ; Garnero P Calcif Tissue Int; 2003 Jan; 72(1):8-17. PubMed ID: 12384813 [TBL] [Abstract][Full Text] [Related]
47. Role of the interleukin-6/interleukin-6 soluble receptor cytokine system in mediating increased skeletal sensitivity to parathyroid hormone in perimenopausal women. Insogna K; Mitnick M; Pascarella J; Nakchbandi I; Grey A; Masiukiewicz U J Bone Miner Res; 2002 Nov; 17 Suppl 2():N108-16. PubMed ID: 12412787 [TBL] [Abstract][Full Text] [Related]
48. Serum concentrations of cross-linked N-telopeptides of type I collagen: new marker for bone resorption in hemodialysis patients. Maeno Y; Inaba M; Okuno S; Yamakawa T; Ishimura E; Nishizawa Y Clin Chem; 2005 Dec; 51(12):2312-7. PubMed ID: 16223890 [TBL] [Abstract][Full Text] [Related]
49. Development and evaluation of C-telopeptide enzyme-linked immunoassay for measurement of bone resorption in mouse serum. Srivastava AK; Bhattacharyya S; Castillo G; Miyakoshi N; Mohan S; Baylink DJ Bone; 2000 Oct; 27(4):529-33. PubMed ID: 11033448 [TBL] [Abstract][Full Text] [Related]
50. New biochemical markers of bone resorption in the study of postmenopausal osteoporosis. de la Piedra C; Traba ML; Dominguez Cabrera C; Sosa Henríquez M Clin Chim Acta; 1997 Sep; 265(2):225-34. PubMed ID: 9385464 [TBL] [Abstract][Full Text] [Related]
51. Changes in urinary excretion of type-I collagen cross-linked C-telopeptide and N-telopeptide in perimenopausal women. Taga M; Shirashu K; Minaguchi H Horm Res; 1998; 49(2):86-90. PubMed ID: 9485177 [TBL] [Abstract][Full Text] [Related]
52. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis. Al-Awadhi A; Olusi S; Al-Zaid N; Prabha K J Rheumatol; 1999 Jun; 26(6):1250-6. PubMed ID: 10381038 [TBL] [Abstract][Full Text] [Related]
53. Suppressive levothyroxine therapy has no significant influence on bone degradation in women with thyroid carcinoma: a comparison with other disorders affecting bone metabolism. Mikosch P; Jauk B; Gallowitsch HJ; Pipam W; Kresnik E; Lind P Thyroid; 2001 Mar; 11(3):257-63. PubMed ID: 11327617 [TBL] [Abstract][Full Text] [Related]
54. Assay for cross-linked carboxyterminal telopeptide of type I collagen (ICTP) unlike CrossLaps assay reflects increased pathological degradation of type I collagen in rheumatoid arthritis. Sassi ML; Aman S; Hakala M; Luukkainen R; Risteli J Clin Chem Lab Med; 2003 Aug; 41(8):1038-44. PubMed ID: 12964811 [TBL] [Abstract][Full Text] [Related]
55. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: the OFELY study. Garnero P; Sornay-Rendu E; Claustrat B; Delmas PD J Bone Miner Res; 2000 Aug; 15(8):1526-36. PubMed ID: 10934651 [TBL] [Abstract][Full Text] [Related]
56. Urinary bone resorption markers in monitoring treatment of symptomatic osteoporosis. Parviainen MT; Jääskeläinen K; Kröger H; Arnala I; Alhava E Clin Chim Acta; 1999 Jan; 279(1-2):145-54. PubMed ID: 10064126 [TBL] [Abstract][Full Text] [Related]
57. Biological variability of serum and urinary N-telopeptides of type I collagen in postmenopausal women. Eastell R; Mallinak N; Weiss S; Ettinger M; Pettinger M; Cain D; Fressland K; Chesnut C J Bone Miner Res; 2000 Mar; 15(3):594-8. PubMed ID: 10750575 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy. Vinholes J; Guo CY; Purohit OP; Eastell R; Coleman RE J Clin Oncol; 1997 Jan; 15(1):131-8. PubMed ID: 8996134 [TBL] [Abstract][Full Text] [Related]
59. Relationships between serum adiponectin, leptin concentrations and bone mineral density, and bone biochemical markers in Chinese women. Wu N; Wang QP; Li H; Wu XP; Sun ZQ; Luo XH Clin Chim Acta; 2010 May; 411(9-10):771-5. PubMed ID: 20184866 [TBL] [Abstract][Full Text] [Related]
60. Evaluation of serum beta-carboxy-terminal cross-linking telopeptide of type I collagen as marker of bone resorption in chronic hemodialysis patients. Reichel H; Roth HJ; Schmidt-Gayk H Nephron Clin Pract; 2004; 98(4):c112-8. PubMed ID: 15627788 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]